SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-22-191776
Filing Date
2022-07-12
Accepted
2022-07-12 08:37:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d738141dsc14d9.htm SC 14D9 618717
2 EX-99.(E)(5) d738141dex99e5.htm EX-99.(E)(5) 64826
  Complete submission text file 0001193125-22-191776.txt   685124
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filed by) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-87481 | Film No.: 221078284
SIC: 2834 Pharmaceutical Preparations